Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
58.68 USD | -2.62% | +4.06% | +47.59% |
Mar. 19 | Morphic Holding Names Simon Cooper as Chief Medical Officer | MT |
Mar. 15 | Keros Therapeutics Shares Rise After FDA Fast Track Designation for Potential Anemia Drug | MT |
Financials (USD)
Sales 2024 * | 5.67M | Sales 2025 * | 22.22K | Capitalization | 2.12B |
---|---|---|---|---|---|
Net income 2024 * | -175M | Net income 2025 * | -200M | EV / Sales 2024 * | 320 x |
Net cash position 2024 * | 304M | Net cash position 2025 * | 123M | EV / Sales 2025 * | 89,714 x |
P/E ratio 2024 * |
-11.2
x | P/E ratio 2025 * |
-10.8
x | Employees | 136 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.64% |
1 day | -2.62% | ||
1 week | +4.06% | ||
Current month | +4.06% | ||
1 month | -6.35% | ||
3 months | +14.14% | ||
6 months | +84.24% | ||
Current year | +47.59% |
Managers | Title | Age | Since |
---|---|---|---|
Jasbir Seehra
CEO | Chief Executive Officer | 68 | 15-11-30 |
Keith Regnante
DFI | Director of Finance/CFO | 54 | 20-01-31 |
Jennifer Lachey
CTO | Chief Tech/Sci/R&D Officer | 51 | 16-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mary Gray
BRD | Director/Board Member | 71 | 20-12-16 |
Carl Gordon
CHM | Chairman | 59 | 20-02-29 |
Jasbir Seehra
CEO | Chief Executive Officer | 68 | 15-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.06% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 58.68 | -2.62% | 212,852 |
24-05-06 | 60.26 | -0.51% | 250,843 |
24-05-03 | 60.57 | +6.08% | 572,094 |
24-05-02 | 57.1 | -1.07% | 344,947 |
24-05-01 | 57.72 | +2.36% | 468,530 |
Delayed Quote Nasdaq, May 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+47.59% | 2.12B | |
+10.44% | 107B | |
+0.82% | 106B | |
+8.24% | 23.47B | |
-13.89% | 21.9B | |
-6.03% | 18.77B | |
-37.26% | 17.85B | |
-10.98% | 16.78B | |
+8.67% | 14.41B | |
+41.08% | 12.86B |
- Stock Market
- Equities
- KROS Stock